Issy Corbett

Issy is a Partner in the London office and Head of Healthcare M&A. Issy has over 12 years of Corporate Finance experience, having previously been at Rothschild. He has advised on a in excess of 50 healthcare transactions, including sell-side, buy-side, IPO, sale & leaseback, refinancing and restructuring. Selected transactions include:

• Advised Jacobs Holdings on its acquisition of Southern Dental
• Advised NFA on its acquisition of Acorn Care & Education
• Advised on the sale of NFA to Sterling Square Partners
• Advised on the IPO of Capio AB
• Advised on the sale of Cancer Partners UK to Genesis Care
• Advised on the sale of Care UK’s mental health, learning disabilities and care at home divisions to Partnerships in Care, Lifeways and Mears respectively
• Advised on the sale of Autism Care to Lifeways
• Advised on the sale and leaseback of MMCG to HCP
• Advised on the sale of Capio Nightingale Hospital to Groupe Sinoué and a sale & leaseback of Capio France to Icade
• Advised on the sale and leaseback for Priory Group to M&G
• Advised on the refinancing of Nuffield Health
• Advised on the IPO of Cambian Group
• Advised Bridgepoint Capital on the acquisition of Oasis Dental
• Advised Colony Capital on the sale of Hôpital de La Tour
• Advised August Equity on the disposal of Lifeways
• Advised Graphite Capital on the acquisition of City & County Healthcare
• Advised on the disposal of Four Seasons Health Care to Terra Firma
• Advised Sovereign Capital on the disposal of NFA to Graphite Capital
• Advised RBS on the disposal of the Priory Group to Advent
• Advised Five Arrows Principal Investments on the acquisition of Kisimul

Issy qualified as a chartered accountant at KPMG after completing a BA in modern history at Oxford University.